Rasna Therapeutics, Inc. Share Price Other OTC
Equities
RASP
US7538881068
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 15.44M 1.23B |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -4M -319M | EV / Sales 2022 | - |
Net Debt 2022 | 180K 14.37M | Net Debt 2023 | 136K 10.84M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
-2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 14.81% |
Managers | Title | Age | Since |
---|---|---|---|
Keeren Shah
DFI | Director of Finance/CFO | 47 | 30/06/16 |
Jules S. Jacob
PRN | Corporate Officer/Principal | - | 30/06/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 31/07/16 |
Willy Simon
CHM | Chairman | 72 | 13/10/20 |
Gary Jacob
BRD | Director/Board Member | 77 | 22/12/20 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |